ONCOCYTE CORP COM NPV (POST REV SPLIT) revenue breakdown overview

ONCOCYTE CORP COM NPV (POST REV SPLIT) revenue for the last year amounted to 1.50 M USD, the most of which — 1.50 M USD — came from its highest performing source at the moment, Diagnostic Tests, the year earlier bringing 958.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought ONCOCYTE CORP COM NPV (POST REV SPLIT) 916.83 k USD, and the year before that — 732.03 k USD.